Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 3
1(50.0%)
2Total
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07140211Phase 3Recruiting

Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis

Role: lead

NCT05897697Completed

Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study

Role: lead

NCT05306821Not ApplicableUnknown

Effectiveness of Interventions for Hospital Medical Thromboprophylaxis: a Bicentric Swiss Quality-improvement Study

Role: lead

All 3 trials loaded